Anne Libby
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 12 | 2024 | 450 | 1.570 |
Why?
| | Mental Health Services | 12 | 2016 | 445 | 1.470 |
Why?
| | Financing, Organized | 4 | 2020 | 35 | 1.250 |
Why?
| | Research Personnel | 5 | 2020 | 176 | 1.100 |
Why?
| | Comparative Effectiveness Research | 4 | 2013 | 163 | 1.000 |
Why?
| | Indians, North American | 6 | 2008 | 655 | 0.850 |
Why?
| | Nonprescription Drugs | 3 | 2016 | 65 | 0.840 |
Why?
| | Substance-Related Disorders | 8 | 2008 | 1100 | 0.800 |
Why?
| | Biomedical Research | 5 | 2020 | 684 | 0.790 |
Why?
| | Antidepressive Agents | 6 | 2015 | 243 | 0.770 |
Why?
| | Managed Care Programs | 10 | 2011 | 140 | 0.760 |
Why?
| | Sex Factors | 8 | 2025 | 2055 | 0.730 |
Why?
| | Depressive Disorder | 6 | 2015 | 375 | 0.700 |
Why?
| | Faculty, Medical | 4 | 2022 | 290 | 0.690 |
Why?
| | Mentoring | 3 | 2022 | 150 | 0.680 |
Why?
| | Capitation Fee | 5 | 2002 | 14 | 0.650 |
Why?
| | Interdisciplinary Research | 1 | 2020 | 26 | 0.640 |
Why?
| | Mental Disorders | 5 | 2017 | 1133 | 0.610 |
Why?
| | Sex Characteristics | 3 | 2022 | 783 | 0.580 |
Why?
| | United States Food and Drug Administration | 4 | 2009 | 197 | 0.560 |
Why?
| | Antihypertensive Agents | 4 | 2025 | 508 | 0.560 |
Why?
| | Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.530 |
Why?
| | Pharmacists | 2 | 2024 | 256 | 0.520 |
Why?
| | Child Welfare | 4 | 2007 | 229 | 0.520 |
Why?
| | Academic Medical Centers | 3 | 2020 | 523 | 0.510 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 28 | 0.510 |
Why?
| | Writing | 1 | 2018 | 99 | 0.510 |
Why?
| | Prescription Drugs | 2 | 2016 | 112 | 0.490 |
Why?
| | Academies and Institutes | 1 | 2016 | 54 | 0.490 |
Why?
| | Mentors | 5 | 2022 | 213 | 0.480 |
Why?
| | Child Abuse | 6 | 2008 | 548 | 0.470 |
Why?
| | Science | 1 | 2016 | 52 | 0.470 |
Why?
| | Contract Services | 3 | 2002 | 11 | 0.460 |
Why?
| | United States | 31 | 2025 | 15298 | 0.460 |
Why?
| | Fee-for-Service Plans | 5 | 2002 | 88 | 0.450 |
Why?
| | Health Policy | 5 | 2016 | 385 | 0.440 |
Why?
| | Quality-Adjusted Life Years | 3 | 2014 | 112 | 0.440 |
Why?
| | Colorado | 17 | 2020 | 4599 | 0.440 |
Why?
| | Child Abuse, Sexual | 3 | 2007 | 83 | 0.430 |
Why?
| | Juvenile Delinquency | 3 | 2004 | 105 | 0.420 |
Why?
| | Dibenzothiazepines | 1 | 2013 | 18 | 0.410 |
Why?
| | Health Care Costs | 2 | 2010 | 417 | 0.410 |
Why?
| | Data Collection | 5 | 2012 | 655 | 0.400 |
Why?
| | Medication Therapy Management | 1 | 2014 | 78 | 0.400 |
Why?
| | Cooperative Behavior | 1 | 2016 | 456 | 0.400 |
Why?
| | Humans | 77 | 2025 | 141284 | 0.400 |
Why?
| | Telemedicine | 2 | 2024 | 893 | 0.400 |
Why?
| | Length of Stay | 2 | 2017 | 1265 | 0.390 |
Why?
| | Videoconferencing | 2 | 2017 | 66 | 0.380 |
Why?
| | Adolescent | 33 | 2017 | 22116 | 0.380 |
Why?
| | Cohort Studies | 13 | 2016 | 5809 | 0.380 |
Why?
| | Suicide, Attempted | 3 | 2015 | 390 | 0.370 |
Why?
| | Physicians | 4 | 2022 | 930 | 0.360 |
Why?
| | Female | 50 | 2025 | 75814 | 0.360 |
Why?
| | Cities | 1 | 2012 | 137 | 0.350 |
Why?
| | Antipsychotic Agents | 1 | 2013 | 208 | 0.350 |
Why?
| | Income | 1 | 2012 | 198 | 0.350 |
Why?
| | Male | 47 | 2025 | 70140 | 0.350 |
Why?
| | Unemployment | 1 | 2010 | 43 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1336 | 0.320 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.320 |
Why?
| | Research Support as Topic | 3 | 2020 | 81 | 0.320 |
Why?
| | Cost of Illness | 1 | 2012 | 311 | 0.320 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 238 | 0.300 |
Why?
| | Depression | 3 | 2014 | 1490 | 0.300 |
Why?
| | Cost-Benefit Analysis | 6 | 2017 | 612 | 0.300 |
Why?
| | Polypharmacy | 2 | 2024 | 89 | 0.300 |
Why?
| | Prescriptions | 1 | 2009 | 74 | 0.300 |
Why?
| | Hypertension | 3 | 2025 | 1250 | 0.290 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5653 | 0.290 |
Why?
| | Multivariate Analysis | 6 | 2017 | 1505 | 0.290 |
Why?
| | Middle Aged | 29 | 2025 | 34658 | 0.280 |
Why?
| | Child, Preschool | 14 | 2017 | 11511 | 0.280 |
Why?
| | Epilepsy | 1 | 2012 | 359 | 0.280 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 189 | 0.280 |
Why?
| | Premature Birth | 1 | 2012 | 363 | 0.270 |
Why?
| | Child | 24 | 2017 | 22390 | 0.270 |
Why?
| | Health Maintenance Organizations | 2 | 2005 | 105 | 0.270 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2007 | 863 | 0.270 |
Why?
| | Chronic Disease | 2 | 2013 | 1807 | 0.270 |
Why?
| | Drug and Narcotic Control | 1 | 2007 | 26 | 0.260 |
Why?
| | Combat Disorders | 1 | 2007 | 41 | 0.260 |
Why?
| | Interview, Psychological | 1 | 2007 | 96 | 0.260 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 181 | 0.260 |
Why?
| | Health Services Accessibility | 3 | 2007 | 1030 | 0.260 |
Why?
| | Research Design | 3 | 2019 | 1105 | 0.250 |
Why?
| | Education, Medical | 2 | 2020 | 271 | 0.250 |
Why?
| | Parents | 3 | 2017 | 1439 | 0.240 |
Why?
| | Longitudinal Studies | 8 | 2016 | 2929 | 0.240 |
Why?
| | Health Behavior | 1 | 2012 | 784 | 0.240 |
Why?
| | Adult | 26 | 2025 | 39319 | 0.240 |
Why?
| | Decision Making | 1 | 2013 | 949 | 0.230 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1078 | 0.230 |
Why?
| | Hypoglycemia | 1 | 2010 | 470 | 0.230 |
Why?
| | Retrospective Studies | 13 | 2025 | 16447 | 0.230 |
Why?
| | Aged | 20 | 2025 | 24836 | 0.230 |
Why?
| | Aged, 80 and over | 9 | 2024 | 7948 | 0.220 |
Why?
| | Family | 2 | 2006 | 677 | 0.220 |
Why?
| | Stress, Psychological | 2 | 2010 | 1124 | 0.220 |
Why?
| | Smoking | 1 | 2012 | 1576 | 0.220 |
Why?
| | Rural Population | 2 | 2007 | 602 | 0.210 |
Why?
| | Parenting | 1 | 2008 | 319 | 0.210 |
Why?
| | Curriculum | 3 | 2020 | 1035 | 0.210 |
Why?
| | Crime | 1 | 2004 | 60 | 0.210 |
Why?
| | Ambulatory Care | 4 | 2014 | 592 | 0.210 |
Why?
| | Suicide | 3 | 2007 | 669 | 0.210 |
Why?
| | Deprescriptions | 1 | 2024 | 32 | 0.200 |
Why?
| | Primary Health Care | 4 | 2024 | 1757 | 0.180 |
Why?
| | Residential Treatment | 1 | 2002 | 28 | 0.180 |
Why?
| | Adolescent Psychiatry | 1 | 2002 | 14 | 0.180 |
Why?
| | Electronic Health Records | 3 | 2015 | 1129 | 0.180 |
Why?
| | Brain Injuries | 2 | 2005 | 503 | 0.180 |
Why?
| | Foster Home Care | 1 | 2003 | 87 | 0.180 |
Why?
| | Anxiety Disorders | 1 | 2005 | 370 | 0.180 |
Why?
| | Criminal Law | 1 | 2002 | 31 | 0.180 |
Why?
| | Infant | 9 | 2017 | 9820 | 0.180 |
Why?
| | Contracts | 1 | 2001 | 11 | 0.180 |
Why?
| | Schizophrenia | 1 | 2005 | 440 | 0.180 |
Why?
| | Logistic Models | 6 | 2017 | 2098 | 0.180 |
Why?
| | Child Psychiatry | 1 | 2002 | 35 | 0.180 |
Why?
| | Blood Pressure | 2 | 2025 | 1740 | 0.170 |
Why?
| | Costs and Cost Analysis | 3 | 2010 | 219 | 0.170 |
Why?
| | Health Surveys | 3 | 2010 | 511 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 539 | 0.170 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 88 | 0.170 |
Why?
| | Severity of Illness Index | 6 | 2014 | 2904 | 0.170 |
Why?
| | Women's Health | 2 | 2020 | 308 | 0.160 |
Why?
| | Hypoglycemic Agents | 1 | 2010 | 1380 | 0.160 |
Why?
| | Organizational Innovation | 2 | 2020 | 128 | 0.160 |
Why?
| | Dementia | 1 | 2024 | 269 | 0.160 |
Why?
| | Dried Blood Spot Testing | 1 | 2021 | 125 | 0.160 |
Why?
| | Education | 1 | 2020 | 107 | 0.150 |
Why?
| | Organophosphates | 1 | 2021 | 178 | 0.150 |
Why?
| | Young Adult | 10 | 2017 | 13727 | 0.150 |
Why?
| | Population Groups | 3 | 2017 | 58 | 0.150 |
Why?
| | Caregivers | 3 | 2024 | 940 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 190 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 674 | 0.140 |
Why?
| | Health Services Research | 3 | 2016 | 401 | 0.140 |
Why?
| | Adenine | 1 | 2021 | 335 | 0.140 |
Why?
| | Foundations | 1 | 2018 | 28 | 0.140 |
Why?
| | Gender Identity | 1 | 2019 | 128 | 0.140 |
Why?
| | Suicidal Ideation | 2 | 2015 | 545 | 0.140 |
Why?
| | Program Evaluation | 5 | 2021 | 919 | 0.140 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 526 | 0.130 |
Why?
| | Program Development | 1 | 2019 | 364 | 0.130 |
Why?
| | Hospital Costs | 2 | 2012 | 123 | 0.130 |
Why?
| | Sexism | 1 | 2018 | 69 | 0.130 |
Why?
| | Attitude to Health | 2 | 2017 | 451 | 0.130 |
Why?
| | Hospitalization | 2 | 2011 | 2264 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2047 | 0.130 |
Why?
| | Public Health Administration | 1 | 1997 | 74 | 0.120 |
Why?
| | Leadership | 1 | 2020 | 388 | 0.120 |
Why?
| | Reminder Systems | 1 | 2017 | 174 | 0.120 |
Why?
| | Risk Factors | 8 | 2012 | 10490 | 0.120 |
Why?
| | Veterans | 1 | 2007 | 1519 | 0.110 |
Why?
| | Immunization | 1 | 2017 | 402 | 0.110 |
Why?
| | Alcoholism | 1 | 2002 | 823 | 0.110 |
Why?
| | Florida | 2 | 2025 | 116 | 0.110 |
Why?
| | Community Mental Health Services | 2 | 2007 | 86 | 0.110 |
Why?
| | Accidents | 2 | 2005 | 45 | 0.110 |
Why?
| | Comorbidity | 3 | 2015 | 1671 | 0.110 |
Why?
| | Quetiapine Fumarate | 1 | 2013 | 24 | 0.100 |
Why?
| | Oregon | 1 | 2013 | 78 | 0.100 |
Why?
| | Health Information Management | 1 | 2013 | 7 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 432 | 0.100 |
Why?
| | Alcohol-Related Disorders | 2 | 2005 | 127 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 695 | 0.100 |
Why?
| | Health Expenditures | 2 | 2006 | 193 | 0.100 |
Why?
| | Decision Support Techniques | 2 | 2014 | 433 | 0.100 |
Why?
| | Minority Groups | 2 | 2022 | 278 | 0.100 |
Why?
| | Medical Audit | 1 | 2013 | 77 | 0.100 |
Why?
| | Age Factors | 5 | 2012 | 3295 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2014 | 1312 | 0.100 |
Why?
| | Regression Analysis | 3 | 2011 | 1013 | 0.100 |
Why?
| | Women's Health Services | 2 | 2006 | 15 | 0.100 |
Why?
| | Interviews as Topic | 2 | 2020 | 839 | 0.100 |
Why?
| | Medical Records Systems, Computerized | 1 | 2013 | 96 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 717 | 0.100 |
Why?
| | Economics, Pharmaceutical | 1 | 2012 | 10 | 0.090 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2012 | 16 | 0.090 |
Why?
| | Education, Graduate | 1 | 2012 | 33 | 0.090 |
Why?
| | Diagnostic Tests, Routine | 1 | 2013 | 110 | 0.090 |
Why?
| | Efficiency | 1 | 2012 | 101 | 0.090 |
Why?
| | Prevalence | 3 | 2011 | 2795 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 128 | 0.090 |
Why?
| | Health Services | 1 | 2012 | 116 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2017 | 802 | 0.090 |
Why?
| | Pilot Projects | 2 | 2024 | 1820 | 0.090 |
Why?
| | Self Care | 1 | 2014 | 387 | 0.090 |
Why?
| | Advisory Committees | 3 | 2007 | 214 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 539 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.090 |
Why?
| | State Health Plans | 2 | 2002 | 33 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 72 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2011 | 49 | 0.090 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2011 | 66 | 0.090 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 103 | 0.090 |
Why?
| | Vomiting | 1 | 2011 | 128 | 0.090 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 88 | 0.080 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2012 | 99 | 0.080 |
Why?
| | Policy Making | 1 | 2011 | 79 | 0.080 |
Why?
| | Employment | 1 | 2012 | 180 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 122 | 0.080 |
Why?
| | Headache | 1 | 2011 | 153 | 0.080 |
Why?
| | Drug Labeling | 2 | 2007 | 38 | 0.080 |
Why?
| | Medicare | 3 | 2024 | 802 | 0.080 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2011 | 99 | 0.080 |
Why?
| | Medication Adherence | 1 | 2014 | 510 | 0.080 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.080 |
Why?
| | Social Support | 2 | 2020 | 629 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2016 | 714 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 479 | 0.080 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1268 | 0.080 |
Why?
| | California | 3 | 2007 | 457 | 0.080 |
Why?
| | Influenza, Human | 2 | 2017 | 630 | 0.080 |
Why?
| | Information Dissemination | 1 | 2011 | 209 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2009 | 61 | 0.070 |
Why?
| | Financing, Government | 2 | 2000 | 49 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2012 | 367 | 0.070 |
Why?
| | Vaccination | 1 | 2017 | 1468 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2007 | 267 | 0.070 |
Why?
| | Community-Institutional Relations | 1 | 2009 | 102 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 353 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 336 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 5948 | 0.070 |
Why?
| | HIV Infections | 2 | 2021 | 2981 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 266 | 0.070 |
Why?
| | Prospective Studies | 3 | 2021 | 7805 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2007 | 48 | 0.070 |
Why?
| | Office Visits | 1 | 2007 | 94 | 0.070 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 771 | 0.070 |
Why?
| | Trauma Severity Indices | 2 | 2005 | 111 | 0.060 |
Why?
| | Drug Utilization | 1 | 2007 | 166 | 0.060 |
Why?
| | Databases, Factual | 4 | 2016 | 1449 | 0.060 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 239 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2012 | 6270 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2005 | 39 | 0.060 |
Why?
| | Physicians, Family | 1 | 2007 | 192 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 741 | 0.060 |
Why?
| | Cost Savings | 2 | 2012 | 86 | 0.060 |
Why?
| | Alcohol Drinking | 1 | 2012 | 834 | 0.060 |
Why?
| | Bone Density | 1 | 2009 | 496 | 0.060 |
Why?
| | Parent-Child Relations | 1 | 2008 | 285 | 0.060 |
Why?
| | Sleep | 1 | 2011 | 882 | 0.050 |
Why?
| | Psychiatry | 1 | 2007 | 188 | 0.050 |
Why?
| | Pregnancy | 2 | 2020 | 7035 | 0.050 |
Why?
| | Northwestern United States | 1 | 2004 | 57 | 0.050 |
Why?
| | Southwestern United States | 1 | 2004 | 94 | 0.050 |
Why?
| | Brain Damage, Chronic | 1 | 2003 | 18 | 0.050 |
Why?
| | Direct Service Costs | 1 | 2003 | 8 | 0.050 |
Why?
| | Age of Onset | 1 | 2005 | 536 | 0.050 |
Why?
| | Volition | 1 | 2003 | 34 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2005 | 237 | 0.050 |
Why?
| | Odds Ratio | 2 | 2004 | 1057 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3024 | 0.050 |
Why?
| | Monte Carlo Method | 2 | 2014 | 150 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 102 | 0.050 |
Why?
| | Somatoform Disorders | 1 | 2003 | 35 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2013 | 11216 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2007 | 579 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 231 | 0.050 |
Why?
| | Rehabilitation, Vocational | 1 | 2002 | 3 | 0.050 |
Why?
| | Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 100 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2003 | 296 | 0.050 |
Why?
| | Calcium Channel Blockers | 1 | 2022 | 173 | 0.040 |
Why?
| | Child Health Services | 2 | 2001 | 196 | 0.040 |
Why?
| | Reimbursement, Incentive | 1 | 2002 | 40 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 197 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2009 | 3577 | 0.040 |
Why?
| | Qualitative Research | 2 | 2020 | 1519 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2022 | 227 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 138 | 0.040 |
Why?
| | Practice Management, Medical | 1 | 2001 | 30 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2002 | 328 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2003 | 374 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2007 | 680 | 0.040 |
Why?
| | Occupational Diseases | 1 | 2002 | 160 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2005 | 538 | 0.040 |
Why?
| | International Classification of Diseases | 2 | 2015 | 141 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 1037 | 0.040 |
Why?
| | Incidence | 2 | 2005 | 2809 | 0.040 |
Why?
| | Pediatrics | 1 | 2007 | 1102 | 0.040 |
Why?
| | Models, Statistical | 1 | 2003 | 669 | 0.040 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 81 | 0.040 |
Why?
| | Health Care Surveys | 2 | 1997 | 561 | 0.040 |
Why?
| | Risk Assessment | 3 | 2015 | 3522 | 0.040 |
Why?
| | Social Stigma | 1 | 2020 | 148 | 0.030 |
Why?
| | Competitive Bidding | 1 | 1997 | 3 | 0.030 |
Why?
| | Career Choice | 1 | 2019 | 233 | 0.030 |
Why?
| | Administrative Personnel | 1 | 1997 | 29 | 0.030 |
Why?
| | Decision Making, Organizational | 1 | 1997 | 26 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3793 | 0.030 |
Why?
| | Specialization | 2 | 2007 | 130 | 0.030 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 108 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2017 | 138 | 0.030 |
Why?
| | Motivation | 1 | 2001 | 600 | 0.030 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2016 | 4 | 0.030 |
Why?
| | Models, Organizational | 1 | 1997 | 143 | 0.030 |
Why?
| | Medicine | 2 | 2007 | 125 | 0.030 |
Why?
| | Citalopram | 1 | 2015 | 34 | 0.030 |
Why?
| | Immunization Programs | 1 | 2017 | 221 | 0.030 |
Why?
| | Fluoxetine | 1 | 2015 | 56 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 273 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 565 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 355 | 0.030 |
Why?
| | Uncertainty | 1 | 2014 | 137 | 0.030 |
Why?
| | Urban Population | 1 | 1997 | 482 | 0.030 |
Why?
| | Probability | 1 | 2014 | 307 | 0.030 |
Why?
| | American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 599 | 0.030 |
Why?
| | Insurance Claim Review | 1 | 2013 | 85 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2017 | 551 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1043 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 855 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2014 | 222 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1999 | 897 | 0.020 |
Why?
| | Schools, Pharmacy | 1 | 2012 | 48 | 0.020 |
Why?
| | Databases as Topic | 1 | 2011 | 68 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 61 | 0.020 |
Why?
| | Faculty | 1 | 2012 | 153 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 204 | 0.020 |
Why?
| | Health Care Rationing | 1 | 2011 | 60 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 915 | 0.020 |
Why?
| | Propensity Score | 1 | 2011 | 337 | 0.020 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 153 | 0.020 |
Why?
| | Legislation, Medical | 1 | 2007 | 11 | 0.020 |
Why?
| | Poverty Areas | 1 | 2007 | 41 | 0.020 |
Why?
| | Crisis Intervention | 1 | 2007 | 33 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1009 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2007 | 102 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2246 | 0.020 |
Why?
| | Students | 1 | 2012 | 644 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 78 | 0.020 |
Why?
| | Ontario | 1 | 2006 | 95 | 0.020 |
Why?
| | Osteoporosis | 1 | 2009 | 242 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2006 | 161 | 0.010 |
Why?
| | Time Factors | 1 | 2016 | 6951 | 0.010 |
Why?
| | Seasons | 1 | 2007 | 547 | 0.010 |
Why?
| | Drug Monitoring | 1 | 2007 | 396 | 0.010 |
Why?
| | Pandemics | 1 | 2011 | 1655 | 0.010 |
Why?
| | Physician Incentive Plans | 1 | 2000 | 8 | 0.010 |
Why?
| | Cost Control | 1 | 2000 | 37 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2005 | 938 | 0.010 |
Why?
| | Multicenter Studies as Topic | 1 | 2002 | 367 | 0.010 |
Why?
| | Adolescent Health Services | 1 | 2001 | 77 | 0.010 |
Why?
| | Workplace | 1 | 2002 | 265 | 0.010 |
Why?
| | Health Care Reform | 1 | 2000 | 109 | 0.010 |
Why?
| | Primary Prevention | 1 | 2000 | 202 | 0.010 |
Why?
| | Interpersonal Relations | 1 | 2002 | 406 | 0.010 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 1999 | 76 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 5222 | 0.010 |
Why?
| | Quality Indicators, Health Care | 1 | 2000 | 304 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1999 | 327 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 713 | 0.010 |
Why?
| | Patient Care Team | 1 | 2002 | 667 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2002 | 1610 | 0.010 |
Why?
| | Prognosis | 1 | 1999 | 4080 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|